The observed association between GPC3 expression and inferior survival aligns with preclinical and translational data implicating GPC3 in tumor growth, angiogenesis, and activation of oncogenic pathways such as WnWnt-catenin and IGF signaling [7,9]. Here, IGF1 is linked to neoplasm.